These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11727846)

  • 1. Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid.
    Slot O
    Scand J Rheumatol; 2001; 30(5):305-7. PubMed ID: 11727846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.
    Hoekstra M; Haagsma CJ; Doelman CJ; van de Laar MA
    Ann Rheum Dis; 2005 Jan; 64(1):141-3. PubMed ID: 15608313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
    Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
    J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
    van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
    Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity.
    Borman P; Taşbaş Ö; Karabulut H; Tukun A; Yorgancıoğlu R
    Rev Bras Reumatol; 2015; 55(6):485-92. PubMed ID: 25687398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
    de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
    Whittle SL; Hughes RA
    Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
    Haagsma CJ; Blom HJ; van Riel PL; van't Hof MA; Giesendorf BA; van Oppenraaij-Emmerzaal D; van de Putte LB
    Ann Rheum Dis; 1999 Feb; 58(2):79-84. PubMed ID: 10343521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
    Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).
    Dhir V; Sandhu A; Kaur J; Pinto B; Kumar P; Kaur P; Gupta N; Sood A; Sharma A; Sharma S
    Arthritis Res Ther; 2015 Jun; 17(1):156. PubMed ID: 26063325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis.
    Tiftikci A; Ozdemir A; Tarcin O; Tarcin O; Inanc N; Sahinoglu S; Direskeneli H; Yavuz S; Uras F; Barut Y
    Rheumatol Int; 2006 Jan; 26(3):191-4. PubMed ID: 15645233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.
    Chaabane S; Messedi M; Akrout R; Ben Hamad M; Turki M; Marzouk S; Keskes L; Bahloul Z; Rebai A; Ayedi F; Maalej A
    Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
    Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
    J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
    van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB
    Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine status in patients with ankylosing spondylitis.
    Wei JC; Jan MS; Yu CT; Huang YC; Yang CC; Tsou HK; Lee HS; Chou CT; Tsay G; Chou MC
    Clin Rheumatol; 2007 May; 26(5):739-42. PubMed ID: 17024318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.